The litigation process is particularly hard on wrongful death claimants
Wrongful death litigation is difficult on claimants for a variety of different reasons.
Wrongful death litigation is difficult on claimants for a variety of different reasons.
A recent article spelled out new interest in the “gut microbome” as an opportunity to control illnesses as diverse as obesity, diabetes, inflammatory bowel disease, and even atherosclerotic disease.
Compared to other "high-income" countries, the US spends more in large part because of increased labor, drug and administrative costs.
A recent article describes new methods of using remote monitoring in intensive care units (ICU).
Focus groups can be useful to learn how regular people (a/k/a not lawyers) think about issues in a case.
While most patients understand they can ask for a second opinion, few actually get one. Unfortunately, for complex cases, second opinions are often valuable.
In a recent New York Times Op Ed, Dr. Ezekiel Emanuel posits that the shrinking number of hospitals is a good thing for patient safety and cost.
Recent studies conclude that “balanced crystalloids” should replace saline as liquid of choice in IV drips for patients.
An "opt out" system would help address the long-standing problem of too few organ donations for the people who need them.
JAMA recently put out guidelines for clinicians to address their patients’ use of weight loss supplements